The ACTA Statistics in Trials Interest Group (ACTA STInG) consists of a group of statisticians and clinicians with an interest in statistics who work in clinical trials across Australia and who wish to promote the practice and recognition of the importance of statistics and the profession within clinical trials. The ACTA STInG was officially launched in October 2015 at the first ACTA annual conference.
The primary aim of the group is to improve the statistical quality of investigator initiated clinical trials within Australia through enhanced collaboration among trial statisticians, and to provide a resource for contacting statisticians working in this particular research field.
The activities of the ACTA STInG are managed by an Executive Committee comprising five members of the interest group who may be contacted via the contact details below.
The specific objectives of the ACTA STInG are:
Membership of the ACTA STInG is free and open to statisticians and clinicians with an interest in statistics who work in clinical trials within Australia and who support the objectives of the group. Membership may be requested here.
As of December 2016, the ACTA STInG consists of 98 statisticians working in clinical trials across Australia, as well as clinicians with an interest in increasing the recognition and importance of statisticians working in clinical trials. Members are from a range of public and private research-focused organisations across Australia and New Zealand, including:
Australian Capital Territory
ACT Health, Canberra
Australian National University, Canberra
Datalytics Pty Ltd, Canberra
Therapeutic Goods Administration, Canberra
New South Wales
Cerebral Palsy Alliance, Sydney
Datapharm Australia, Sydney
Melanoma Research Institute, Wollstonecraft
NHMRC Clinical Trials Unit, Sydney
Paediatric Trials Network Australia, Sydney
The George Institute for Global Health, Sydney
The Kirby Institute, Sydney
The University of New South Wales, Sydney
The University of Sydney
The Westmead Institute for Medical Research, Sydney
University of Technology, Sydney
WriteSource Medical Pty Ltd, Sydney
Menzies School of Health Research, Darwin
Royal Darwin Hospital
Australasian Kidney Trials Network, Brisbane
Griffith University, Brisbane
Integrated Health Group Pty Ltd, Brisbane
QIMR Berghofer Medical Research Institute, Brisbane
University of Queensland, Brisbane
CPR Pharma Services, Adelaide
Flinders University, Adelaide
South Australian Health and Medical Research Institute (SAHMRI), Adelaide
The University of Adelaide
Australasian Cochrane Centre, Melbourne
Centre for Eye Research, Melbourne
Melbourne Children’s Trials Centre at the Royal Children’s Hospital
Monash University, Melbourne
Peter MacCallum Cancer Centre, Melbourne
Swinburne University of Technology, Melbourne
The Alfred Hospital, Melbourne
The Florey Institute for Neuroscience and Mental Health, Melbourne
The Royal Melbourne Hospital, Melbourne
The University of Melbourne, Melbourne
Princess Margaret Hospital, Perth
The Telethon Institute, Perth
The University of Notre Dame, Fremantle
University of Western Australia, Perth
Cancer Trials New Zealand, The University of Auckland
The Executive committee for the ACTA STInG consists of the following five members:
If you would like to contact a member of the Executive committee please use the contact details below.
One request that came up at the various meetings of the ACTA-STInG was to provide advice for applying for funding for statistical support for a trial and methodological research. In response to this request we have put together some guidance based on our experience of applying for competitive funding, which can be found at ACTA_STInG_Grant_Advice_
Joint International Society for Clinical Biostatistics and Australian Statistical Conference 2018
When: 26 – 30 August 2018
Where: Melbourne Convention and Exhibition Centre
The aim of this joint conference is to bring together a broad range of statistical researchers across a variety of research areas to facilitate the international exchange of theory, methods and applications.
See http://iscbasc2018.com/ for more information.
One of the objectives of the ACTA STInG is “To develop a structured support network for trial statisticians across Australia, within which different centres provide specialist support for particular trial designs or clinical areas.” In order for us develop a better understanding of the landscape of statistical input and experience in trials across the country, we conducted a short survey of ACTA STInG members. We also asked members how ACTA STInG can be used to improve recognition of and collaboration between statisticians. This survey was completed by 68 members of the group.
The CONSORT (Consolidated Standards of Reporting Trials) statement – s an evidence-based, minimum set of recommendations for reporting randomized trials.
ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)
EQUATOR network (Enhancing the QUAlity and Transparency Of health Research)
Guidelines for the Content of Statistical Analysis Plans in Clincal Trials (Journal of the American Medical Association)
Explainer: how do drugs get from the point of discovery to the pharmacy shelf? (The Conversation; 11 October 2017)
Randomised control trials: what makes them the gold standard in medical research? (The Conversation; 11 October 2017)
Enquiries about the ACTA Statistics in Trials Interest Group can be sent to STInG@clinicaltrialsalliance.org.au